{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:28:38Z","timestamp":1786994918766,"version":"build-2736575974"},"reference-count":225,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012654","name":"Olga Mayenfisch Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012654","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008494","name":"Vontobel-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008494","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008273","name":"Novartis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110587","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T11:08:54Z","timestamp":1751972934000},"page":"110587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Role of amylin in feeding and satiation"],"prefix":"10.1016","volume":"278","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5056-8548","authenticated-orcid":false,"given":"Thomas A.","family":"Lutz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110587_bib1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fendo.2017.00324","article-title":"Involvement of amylin and leptin in the development of projections from the area postrema to the nucleus of the solitary tract","volume":"8","author":"Abegg","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib2","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1152\/ajpendo.00121.2014","article-title":"A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats","volume":"307","author":"Andreassen","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib3","first-page":"R1537","article-title":"Sufficiency of postprandial plasma levels of islet amyloid polypeptide for suppression of feeding in rats","volume":"275","author":"Arnelo","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib4","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1111\/ejn.15376","article-title":"A selective role for receptor activity-modifying proteins in subchronic action of the amylin selective receptor agonist NN1213 compared with salmon calcitonin on body weight and food intake in Male mice","volume":"54","author":"Arrigoni","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110587_bib5","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.appet.2011.05.112","article-title":"Estradiol (E2) increases the acute eating-inhibitory effect of amylin in ovariectomized (OVX) rats","volume":"57S","author":"Asarian","year":"2011","journal-title":"Appetite"},{"key":"10.1016\/j.neuropharm.2025.110587_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.regpep.2009.12.004","article-title":"Pancreatic beta-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes","volume":"160","author":"Asmar","year":"2010","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2025.110587_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1476-5381.2011.01717.x","article-title":"Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes","volume":"166","author":"Bailey","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib8","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1038\/npp.2014.153","article-title":"Amylin receptor signaling in the nucleus accumbens negatively modulates mu-opioid-driven feeding","volume":"39","author":"Baisley","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110587_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0196-9781(91)90038-Q","article-title":"Syntheses, structures and anorectic effects of human and rat amylin","volume":"12","author":"Balasubramaniam","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2025.110587_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cmet.2013.12.015","article-title":"Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain","volume":"19","author":"Balland","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","article-title":"Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin","volume":"19","author":"Banks","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2025.110587_bib12","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/0024-3205(95)02197-Q","article-title":"Permeability of the blood-brain barrier to amylin","volume":"57","author":"Banks","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2025.110587_bib13","doi-asserted-by":"crossref","first-page":"12015","DOI":"10.1073\/pnas.1713074114","article-title":"GPCRs globally coevolved with receptor activity-modifying proteins, RAMPs","volume":"114","author":"Barbash","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110587_bib14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.isci.2018.12.024","article-title":"Detection of concordance between transcriptional levels of GPCRs and receptor-activity-modifying proteins","volume":"11","author":"Barbash","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.neuropharm.2025.110587_bib15","doi-asserted-by":"crossref","first-page":"10455","DOI":"10.1073\/pnas.94.19.10455","article-title":"Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice","volume":"94","author":"Barrachina","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110587_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-3940(03)00190-3","article-title":"Differential effects of amylin and salmon calcitonin on neuropeptide gene expression in the lateral hypothalamic area and the arcuate nucleus of the rat","volume":"341","author":"Barth","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110587_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0006-8993(99)01974-5","article-title":"Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight","volume":"848","author":"Baskin","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110587_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2007.06.016","article-title":"Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK","volume":"1162","author":"Becskei","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110587_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainres.2004.10.012","article-title":"Immunohistochemical mapping of calcitonin receptors in the adult rat brain","volume":"1030","author":"Becskei","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110587_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1152\/advan.00167.2012","article-title":"Interactions between the central nervous system and pancreatic islet secretions: a historical perspective","volume":"37","author":"Begg","year":"2013","journal-title":"Adv. Physiol. Educ."},{"key":"10.1016\/j.neuropharm.2025.110587_bib21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0031-9384(98)00110-3","article-title":"Synergy between amylin and cholecystokinin for inhibition of food intake in mice","volume":"64","author":"Bhavsar","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib22","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0133-24.2024","article-title":"Ventral tegmental area amylin receptor activation differentially modulates mesolimbic dopamine signaling in response to fat versus sugar","volume":"11","author":"Bhimani","year":"2024","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2025.110587_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101444","article-title":"Hypophagia induced by salmon calcitonin, but not by amylin, is partially driven by malaise and is mediated by CGRP neurons","volume":"58","author":"Boccia","year":"2022","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170366","article-title":"Amylin brain circuitry","volume":"132","author":"Boccia","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2025.110587_bib25","doi-asserted-by":"crossref","first-page":"15448","DOI":"10.1096\/fj.202001456RRR","article-title":"Noradrenaline signaling in the LPBN mediates amylin's and salmon calcitonin's hypophagic effect in Male rats","volume":"34","author":"Boccia","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2025.110587_bib26","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/bph.13496","article-title":"Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development","volume":"173","author":"Bower","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuroscience.2019.11.034","article-title":"Amylin and leptin interaction: role during pregnancy, lactation and neonatal development","volume":"447","author":"Boyle","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110587_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.molmet.2017.11.009","article-title":"Amylin - its role in the homeostatic and Hedonic control of eating and recent developments of amylin analogs to treat obesity","volume":"8","author":"Boyle","year":"2018","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.physbeh.2011.04.044","article-title":"Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin","volume":"104","author":"Boyle","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib30","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1111\/ejn.12672","article-title":"The role of the area postrema in the anorectic effects of amylin and salmon calcitonin: behavioral and neuronal phenotyping","volume":"40","author":"Braegger","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110587_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s42255-021-00344-4","article-title":"Central and peripheral GLP-1 systems independently suppress eating","volume":"3","author":"Brierley","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib33","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nn.4574","article-title":"Cancer-induced anorexia and malaise are mediated by CGRP neurons in the parabrachial nucleus","volume":"20","author":"Campos","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110587_bib34","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cmet.2016.04.006","article-title":"Parabrachial CGRP neurons control meal termination","volume":"23","author":"Campos","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib35","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1021\/acs.biochem.4c00114","article-title":"Cryo-EM structure of the human amylin 1 receptor in complex with CGRP and Gs protein","volume":"63","author":"Cao","year":"2024","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2025.110587_bib36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41589-023-01393-4","article-title":"Structural insight into selectivity of amylin and calcitonin receptor agonists","volume":"20","author":"Cao","year":"2024","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm9609","article-title":"A structural basis for amylin receptor phenotype","volume":"375","author":"Cao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110587_bib38","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1523\/JNEUROSCI.3729-14.2015","article-title":"Parabrachial calcitonin gene-related peptide neurons mediate conditioned taste aversion","volume":"35","author":"Carter","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110587_bib162","article-title":"Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3","volume":"118","author":"Carvas","year":"2025","journal-title":"Lancet - eBioMedicine"},{"key":"10.1016\/j.neuropharm.2025.110587_bib39","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/en.2016-1755","article-title":"RAMP2 influences glucagon receptor pharmacology via trafficking and signaling","volume":"158","author":"Cegla","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2025.110587_bib40","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0196-9781(92)90057-A","article-title":"Tests of adipsia and conditioned taste aversion following the intrahypothalamic injection of amylin","volume":"13","author":"Chance","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2025.110587_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(93)91505-M","article-title":"Anorexia following the systemic injection of amylin","volume":"607","author":"Chance","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110587_bib42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0006-8993(91)91644-G","article-title":"Anorexia following the intrahypothalamic administration of amylin","volume":"539","author":"Chance","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110587_bib43","doi-asserted-by":"crossref","first-page":"R1798","DOI":"10.1152\/ajpregu.00386.2007","article-title":"Effects of intermittent intraperitoneal infusion of salmon calcitonin on food intake and adiposity in Obese rats","volume":"293","author":"Chelikani","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2025.110587_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/dom.13401","article-title":"Islet prohormone processing in health and disease","volume":"20","author":"Chen","year":"2018","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cmet.2019.12.012","article-title":"Calcitonin receptor neurons in the mouse nucleus tractus solitarius control energy balance via the non-aversive suppression of feeding","volume":"31","author":"Cheng","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib46","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1074\/jbc.C200629200","article-title":"Novel receptor partners and function of receptor activity-modifying proteins","volume":"278","author":"Christopoulos","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110587_bib47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.56.1.235","article-title":"Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product","volume":"56","author":"Christopoulos","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(87)90825-7","article-title":"Islet amyloid formed from diabetes-associated peptide May be pathogenic in type-2 diabetes","volume":"2","author":"Clark","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2025.110587_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2020.112992","article-title":"Viral depletion of calcitonin receptors in the area postrema: a proof-of-concept study","volume":"223","author":"Coester","year":"2020","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib50","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2337\/db19-0849","article-title":"Amylin\/calcitonin receptor-mediated signaling in POMC neurons influences energy balance and locomotor activity in chow-fed Male mice","volume":"69","author":"Coester","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2025.110587_bib51","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuroscience.2019.11.036","article-title":"RAMP1 and RAMP3 differentially control amylin's effects on food intake, glucose and energy balance in Male and female mice","volume":"447","author":"Coester","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110587_bib52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/edrv-15-2-163","article-title":"Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease","volume":"15","author":"Cooper","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuropharm.2025.110587_bib53","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110587_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(25)01185-7","article-title":"Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b\/2a randomised controlled study","author":"Dahl","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2025.110587_bib55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbr.2007.05.001","article-title":"Histamine H1-receptors differentially mediate the action of amylin on hypothalamic neurons in control and in overweight rats","volume":"182","author":"Davidowa","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110587_bib56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.7570\/jomes21071","article-title":"Amylin as a future obesity treatment","volume":"30","author":"Dehestani","year":"2021","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.neuropharm.2025.110587_bib57","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","article-title":"The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors","volume":"32","author":"Dickson","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110587_bib58","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1471-4159.2009.06422.x","article-title":"Central amylin expression and its induction in rat dams","volume":"111","author":"Dobolyi","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110587_bib59","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s42255-021-00432-5","article-title":"Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function","volume":"3","author":"Duquenne","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib60","article-title":"Area postrem (AP)-Lesions block the regulation of gastric emptying by amylin","volume":"10","author":"Edwards","year":"1998","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2025.110587_bib61","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1113\/jphysiol.2002.018671","article-title":"Salmon calcitonin - a potent inhibitor of food intake in states of impaired leptin signalling in laboratory rodents","volume":"541","author":"Eiden","year":"2002","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib62","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(21)00845-X","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2\u00b74 mg for weight management: a randomised, controlled, phase 1b trial","volume":"397","author":"Enebo","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2025.110587_bib63","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/meta.2002.32022","article-title":"The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes","volume":"51","author":"Fineman","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.neuropharm.2025.110587_bib64","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1042\/bst0300455","article-title":"Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs)","volume":"30","author":"Fischer","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2025.110587_bib65","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/jpet.121.000567","article-title":"AM833 is a novel agonist of calcitonin family G protein-coupled receptors: pharmacological comparison with six selective and nonselective agonists","volume":"377","author":"Fletcher","year":"2021","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110587_bib66","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0140-6736(23)01163-7","article-title":"Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial","volume":"402","author":"Frias","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2025.110587_bib67","first-page":"14","article-title":"Making sense of it: roles of the sensory circumventricular organs in feeding and regulation of energy homeostasis","volume":"232","author":"Fry","year":"2007","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.neuropharm.2025.110587_bib68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2012.11.051","article-title":"Electrophysiologically identified presynaptic mechanisms underlying amylinergic modulation of area postrema neuronal excitability in rat brain slices","volume":"1494","author":"Fukuda","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110587_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(25)01176-6","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial","author":"Gasiorek","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2025.110587_bib71","doi-asserted-by":"crossref","first-page":"R1444","DOI":"10.1152\/ajpregu.00066.2005","article-title":"A new way of looking at eating","volume":"288","author":"Geary","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib72","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.regpep.2006.06.004","article-title":"Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist","volume":"137","author":"Gedulin","year":"2006","journal-title":"AC187. Regul Pept"},{"key":"10.1016\/j.neuropharm.2025.110587_bib73","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.regpep.2006.06.004","article-title":"Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist","volume":"137","author":"Gedulin","year":"2006","journal-title":"AC187. Regulatory peptides"},{"key":"10.1016\/j.neuropharm.2025.110587_bib74","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0026-0495(97)90170-0","article-title":"Dose-response for glucagonostatic effect of amylin in rats","volume":"46","author":"Gedulin","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.neuropharm.2025.110587_bib75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0026-0495(97)90170-0","article-title":"Dose-response for glucagonostatic effect of amylin in rats","volume":"46","author":"Gedulin","year":"1997","journal-title":"Metab., Clin. Exp."},{"key":"10.1016\/j.neuropharm.2025.110587_bib76","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2337\/diab.47.1.93","article-title":"Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats","volume":"47","author":"Gedulin","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2025.110587_bib77","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.biopsych.2023.07.011","article-title":"Amylin modulates a ventral tegmental area-to-medial prefrontal cortex circuit to suppress food intake and impulsive food-directed behavior","volume":"95","author":"Geisler","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110587_bib78","article-title":"Amylin receptor subunit interactions are modulated by agonists and determine signaling","author":"Gostynska","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuropharm.2025.110587_bib79","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1208\/s12249-013-9987-4","article-title":"Preparation and characterization of PEGylated amylin","volume":"14","author":"Guerreiro","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.neuropharm.2025.110587_bib80","first-page":"136","article-title":"Ventral tegmental area amylin\/calcitonin receptor signaling suppresses feeding and weight gain in female rats","volume":"212","author":"Gustafson","year":"2025","journal-title":"Ventral Tegmental Area Amylin Receptor Activation Differentially Modulates Mesolimbic Dopamine Signaling in Response to Fat versus Sugar. Neurosci Res"},{"key":"10.1016\/j.neuropharm.2025.110587_bib81","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biochi.2024.10.012","article-title":"Central nervous system pathways targeted by amylin in the regulation of food intake","volume":"229","author":"Hankir","year":"2025","journal-title":"Biochimie"},{"key":"10.1016\/j.neuropharm.2025.110587_bib82","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/pr.115.010629","article-title":"Amylin: pharmacology, physiology, and clinical potential","volume":"67","author":"Hay","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110587_bib83","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1124\/mol.104.008615","article-title":"Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes","volume":"67","author":"Hay","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib84","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bph.14075","article-title":"Update on the pharmacology of calcitonin\/CGRP family of peptides: IUPHAR review 25","volume":"175","author":"Hay","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1124\/pr.108.00372","article-title":"International union of pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor","volume":"60","author":"Hay","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110587_bib86","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1042\/BST20150237","article-title":"Receptor activity-modifying proteins; multifunctional G protein-coupled receptor accessory proteins","volume":"44","author":"Hay","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2025.110587_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2021.113435","article-title":"Hypoglycemia attenuates acute amylin-induced reduction of food intake in Male rats","volume":"237","author":"Honegger","year":"2021","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib88","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2337\/dc07-2433","article-title":"Leptin does not directly regulate the pancreatic hormones amylin and pancreatic polypeptide: interventional studies in humans","volume":"31","author":"Hwang","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neuropharm.2025.110587_bib89","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2022.06.002","article-title":"Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions","volume":"34","author":"Imbernon","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib90","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-2007-1003714","article-title":"Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas","volume":"23","author":"Inoue","year":"1991","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.neuropharm.2025.110587_bib91","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000084488","article-title":"Chronically administered islet amyloid polypeptide in rats serves as an adiposity inhibitor and regulates energy homeostasis","volume":"5","author":"Isaksson","year":"2005","journal-title":"Pancreatology"},{"key":"10.1016\/j.neuropharm.2025.110587_bib92","first-page":"416","article-title":"Spontaneous diabetes mellitus-islet amyloid complex in adult cats","volume":"125","author":"Johnson","year":"1986","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib93","doi-asserted-by":"crossref","first-page":"R1032","DOI":"10.1152\/ajpregu.00326.2016","article-title":"Early postnatal amylin treatment enhances hypothalamic leptin signaling and neural development in the selectively bred diet-induced Obese rat","volume":"311","author":"Johnson","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib94","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/adb.12603","article-title":"Activation of amylin receptors attenuates alcohol-mediated behaviours in rodents","volume":"24","author":"Kalafateli","year":"2019","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib95","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/molpharm.123.000865","article-title":"Development of a novel assay for direct assessment of selective amylin receptor activation reveals novel differences in behavior of selective and nonselective peptide agonists","volume":"105","author":"Keov","year":"2024","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2020.112958","article-title":"Distributed amylin receptor signaling and its influence on motivated behavior","volume":"222","author":"Kern","year":"2020","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib97","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s001250050646","article-title":"Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM","volume":"40","author":"Kong","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.neuropharm.2025.110587_bib98","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s001250050949","article-title":"The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM","volume":"41","author":"Kong","year":"1998","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110587_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pharmrev.120.000180","article-title":"Elucidating the interactome of G protein-coupled receptors (GPCRs) and receptor activity-modifying proteins (RAMPs)","volume":"75","author":"Kotliar","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110587_bib100","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1039\/C4OB01208A","article-title":"Convergent chemoenzymatic synthesis of a library of glycosylated analogues of pramlintide: structure-activity relationships for amylin receptor agonism","volume":"12","author":"Kowalczyk","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110587_bib101","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1021\/acs.jmedchem.1c00565","article-title":"Development of cagrilintide, a long-acting amylin analogue","volume":"64","author":"Kruse","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2025.110587_bib102","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1021\/acs.jmedchem.1c00565","article-title":"Development of cagrilintide, a long-acting amylin analogue","volume":"64","author":"Kruse","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2025.110587_bib103","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(21)01751-7","article-title":"Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial","volume":"398","author":"Lau","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2025.110587_bib104","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2337\/db14-0645","article-title":"Amylin-induced central IL-6 production enhances ventromedial hypothalamic leptin signaling","volume":"64","author":"Le Foll","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2025.110587_bib105","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/j.2040-4603.2020.tb00140.x","article-title":"Systemic and central amylin, amylin receptor signaling, and their physiological and pathophysiological roles in metabolism","volume":"10","author":"Le Foll","year":"2020","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib106","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/protein\/gzz036","article-title":"Amyloidogenicity and cytotoxicity of des-Lys-1 human amylin provides insight into amylin self-assembly and highlights the difficulties of defining amyloidogenicity","volume":"32","author":"Lee","year":"2019","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.neuropharm.2025.110587_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175912","article-title":"Body weight lowering effect of glucose-dependent insulinotropic polypeptide and glucagon-like peptide receptor agonists is more efficient in RAMP1\/3 KO than in WT mice","volume":"955","author":"Leuthardt","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib108","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tem.2016.11.004","article-title":"Amylin and leptin: co-regulators of energy homeostasis and neuronal development","volume":"28","author":"Levin","year":"2017","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3149","article-title":"Melanocortin 4 receptor-mediated effects of amylin on thermogenesis and regulation of food intake","volume":"35","author":"Li","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.neuropharm.2025.110587_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmet.2015.10.012","article-title":"Hypothalamic amylin acts in concert with leptin to regulate food intake","volume":"22","author":"Li","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib111","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.cmet.2016.04.014","article-title":"Hypothalamic amylin acts in concert with leptin to regulate food intake","volume":"23","author":"Li","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib112","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.molmet.2016.06.015","article-title":"The satiating hormone amylin enhances neurogenesis in the area postrema of adult rats","volume":"5","author":"Liberini","year":"2016","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib113","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/ejn.13163","article-title":"Amylin receptor components and the leptin receptor are co-expressed in single rat area postrema neurons","volume":"43","author":"Liberini","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110587_bib114","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.peptides.2018.10.006","article-title":"RAMP3 deficiency enhances postmenopausal obesity and metabolic disorders","volume":"110","author":"Liu","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2025.110587_bib115","article-title":"Multiplexed analysis of the secretin-like GPCR-RAMP interactome","author":"Lorenzen","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuropharm.2025.110587_bib116","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s42255-021-00363-1","article-title":"A genetic map of the mouse dorsal vagal complex and its role in obesity","volume":"3","author":"Ludwig","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib117","article-title":"A cross-species atlas of the dorsal vagal complex reveals neural mediators of cagrilintide\u2019s effects on energy balance","author":"Ludwig","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuropharm.2025.110587_bib118","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.physbeh.2006.04.001","article-title":"Amylinergic control of food intake","volume":"89","author":"Lutz","year":"2006","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib119","doi-asserted-by":"crossref","first-page":"R1475","DOI":"10.1152\/ajpregu.00703.2009","article-title":"The role of amylin in the control of energy homeostasis","volume":"298","author":"Lutz","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000264394","article-title":"Roles of amylin in satiation, adiposity and brain development","volume":"63","author":"Lutz","year":"2010","journal-title":"Forum Nutr."},{"key":"10.1016\/j.neuropharm.2025.110587_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.appet.2022.105965","article-title":"Creating the amylin story","volume":"172","author":"Lutz","year":"2022","journal-title":"Appetite"},{"key":"10.1016\/j.neuropharm.2025.110587_bib122","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.biopsych.2024.02.1008","article-title":"Amylin, the prefrontal cortex, and impulsive eating","volume":"95","author":"Lutz","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110587_bib123","first-page":"R1777","article-title":"Anorectic effect of amylin is not transmitted by capsaicin-sensitive nerve fibers","volume":"274","author":"Lutz","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib124","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2337\/db17-1347","article-title":"Amylin selectively signals onto POMC neurons in the arcuate nucleus of the hypothalamus","volume":"67","author":"Lutz","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2025.110587_bib125","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0031-9384(94)90076-0","article-title":"Reduction of food intake in rats by intraperitoneal injection of low doses of amylin","volume":"55","author":"Lutz","year":"1994","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib126","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0196-9781(94)00203-I","article-title":"Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin","volume":"16","author":"Lutz","year":"1995","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2025.110587_bib127","series-title":"Appetite and Food Intake: Behavioral and Physiological Consideration","first-page":"163","article-title":"Gastrointestinal factors in appetite and food research - animal research","author":"Lutz","year":"2008"},{"key":"10.1016\/j.neuropharm.2025.110587_bib128","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0031-9384(95)02067-5","article-title":"Amylin decreases meal size in rats","volume":"58","author":"Lutz","year":"1995","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib129","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0031-9384(95)02067-5","article-title":"Amylin decreases meal size in rats","volume":"58","author":"Lutz","year":"1995","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib130","doi-asserted-by":"crossref","first-page":"R791","DOI":"10.1152\/ajpregu.00004.2019","article-title":"Endogenous amylin contributes to birth of microglial cells in arcuate nucleus of hypothalamus and area postrema during fetal development","volume":"316","author":"Lutz","year":"2019","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib131","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.ijo.0801664","article-title":"The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema\/nucleus of the solitary tract (AP\/NTS) lesioned rats","volume":"25","author":"Lutz","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.neuropharm.2025.110587_bib132","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MOL.0000000000000293","article-title":"Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism","volume":"27","author":"Lutz","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib133","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0195-5616(95)50051-8","article-title":"Pathogenesis of feline diabetes mellitus","volume":"25","author":"Lutz","year":"1995","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.neuropharm.2025.110587_bib134","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0021-9975(97)80073-4","article-title":"Detection of amyloid deposition in various regions of the feline pancreas by different staining techniques","volume":"116","author":"Lutz","year":"1997","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0196-9781(97)00292-1","article-title":"Lesion of the area postrema\/nucleus of the solitary tract (AP\/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats","volume":"19","author":"Lutz","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2025.110587_bib136","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0196-9781(99)00208-9","article-title":"Amylin receptors mediate the anorectic action of salmon calcitonin (sCT)","volume":"21","author":"Lutz","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2025.110587_bib137","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1210\/jcem.86.12.8107","article-title":"Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging","volume":"86","author":"MacIntosh","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib138","doi-asserted-by":"crossref","first-page":"R1855","DOI":"10.1152\/ajpregu.00297.2007","article-title":"Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight","volume":"293","author":"Mack","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib139","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ijo.2009.238","article-title":"Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight","volume":"34","author":"Mack","year":"2010","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.neuropharm.2025.110587_bib140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diabetes.53.1.141","article-title":"Role of beta-cell prohormone convertase (PC)1\/3 in processing of pro-islet amyloid polypeptide","volume":"53","author":"Marzban","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2025.110587_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2024.107201","article-title":"The processing intermediate of human amylin, pro-amylin(1-48), has in vivo and in vitro bioactivity","volume":"308","author":"Mazzini","year":"2024","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.neuropharm.2025.110587_bib142","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110587_bib143","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000107579","article-title":"Diet-derived nutrients modulate the effects of amylin on c-Fos expression in the area postrema and on food intake","volume":"86","author":"Michel","year":"2007","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2025.110587_bib144","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.physbeh.2014.01.013","article-title":"Amylin activates distributed CNS nuclei to control energy balance","volume":"136","author":"Mietlicki-Baase","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2017.05.024","article-title":"Amylin receptor activation in the ventral tegmental area reduces motivated ingestive behavior","volume":"123","author":"Mietlicki-Baase","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110587_bib146","doi-asserted-by":"crossref","first-page":"E1367","DOI":"10.1152\/ajpendo.00413.2013","article-title":"The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA\/Kainate receptors","volume":"305","author":"Mietlicki-Baase","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib147","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/npp.2014.180","article-title":"Amylin modulates the mesolimbic dopamine system to control energy balance","volume":"40","author":"Mietlicki-Baase","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110587_bib148","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/npp.2013.66","article-title":"Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake","volume":"38","author":"Mietlicki-Baase","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110587_bib149","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.physbeh.2004.01.006","article-title":"Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats","volume":"81","author":"Mollet","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0196-9781(02)00280-2","article-title":"Endogenous amylin contributes to the anorectic effects of cholecystokinin and bombesin","volume":"24","author":"Mollet","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2025.110587_bib151","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0091-3057(96)00168-2","article-title":"Amylin and food intake in mice: effects on motivation to eat and mechanism of action","volume":"56","author":"Morley","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib152","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1210\/endo.140.6.6930","article-title":"An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3","volume":"140","author":"Muff","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2025.110587_bib153","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1523\/JNEUROSCI.15-11-07625.1995","article-title":"Islet amyloid polypeptide (Amylin) is expressed in sensory neurons","volume":"15","author":"Mulder","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110587_bib154","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","article-title":"Anti-obesity drug discovery: advances and challenges","volume":"21","author":"Muller","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2025.110587_bib155","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1113\/EP088356","article-title":"Palatable food access impacts expression of amylin receptor components in the mesocorticolimbic system","volume":"105","author":"Nashawi","year":"2020","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib156","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/jcem.87.3.8355","article-title":"Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers","volume":"87","author":"Nauck","year":"2002","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib157","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1677\/jme.0.0090157","article-title":"Extra-pancreatic expression of the rat islet amyloid polypeptide (Amylin) gene","volume":"9","author":"Nicholl","year":"1992","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib158","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1021\/acschembio.9b01050","article-title":"Analysis of amylin consensus sequences suggests that human amylin is not optimized to minimize amyloid formation and provides clues to factors that modulate amyloidogenicity","volume":"15","author":"Noh","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib159","first-page":"1083","article-title":"Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitus","volume":"81","author":"Nyholm","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib160","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0026-0495(99)90232-9","article-title":"The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus","volume":"48","author":"Nyholm","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.neuropharm.2025.110587_bib161","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI114528","article-title":"Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment","volume":"85","author":"Ogawa","year":"1990","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2025.110587_bib163","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.0953-816x.2001.01688.x","article-title":"Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat","volume":"14","author":"Oliver","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110587_bib164","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.peptides.2007.06.011","article-title":"Comparison of the effects of chronic central administration and chronic peripheral administration of islet amyloid polypeptide on food intake and meal pattern in the rat","volume":"28","author":"Olsson","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2025.110587_bib165","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.physbeh.2007.03.017","article-title":"Modulation of the satiating effect of amylin by central ghrelin, leptin and insulin","volume":"91","author":"Osto","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib166","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1210\/en.2017-03259","article-title":"Essential role for hypothalamic calcitonin ReceptorExpressing neurons in the control of food intake by leptin","volume":"159","author":"Pan","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2025.110587_bib167","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.physbeh.2010.03.001","article-title":"Brainstem mechanisms of amylin-induced anorexia","volume":"100","author":"Potes","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib168","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2010.03.114","article-title":"Identification of central projections from amylin-activated neurons to the lateral hypothalamus","volume":"1334","author":"Potes","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110587_bib169","doi-asserted-by":"crossref","first-page":"R623","DOI":"10.1152\/ajpregu.00791.2009","article-title":"Noradrenergic neurons of the area postrema mediate amylin's hypophagic action","volume":"299","author":"Potes","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pr.54.2.233","article-title":"International union of pharmacology. XXXII. The Mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors","volume":"54","author":"Poyner","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110587_bib171","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.85640","article-title":"Multiple NTS neuron populations cumulatively suppress food intake","volume":"12","author":"Qiu","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2025.110587_bib172","doi-asserted-by":"crossref","first-page":"R605","DOI":"10.1152\/ajpregu.2001.280.3.R605","article-title":"Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats","volume":"280","author":"Reidelberger","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib173","doi-asserted-by":"crossref","first-page":"R568","DOI":"10.1152\/ajpregu.00213.2004","article-title":"Amylin receptor blockade stimulates food intake in rats","volume":"287","author":"Reidelberger","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib174","doi-asserted-by":"crossref","first-page":"R1395","DOI":"10.1152\/ajpregu.00597.2001","article-title":"Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats","volume":"282","author":"Reidelberger","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110587_bib175","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.biopsych.2016.12.028","article-title":"Amylin acts in the lateral dorsal tegmental nucleus to regulate energy balance through gamma-aminobutyric acid signaling","volume":"82","author":"Reiner","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110587_bib176","first-page":"854","article-title":"The ability of amylin to reduce eating depends on the protein content of the diet","volume":"52","author":"Riediger","year":"2009","journal-title":"Appetite"},{"key":"10.1016\/j.neuropharm.2025.110587_bib177","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3940(02)00482-2","article-title":"Amylin and glucose co-activate area postrema neurons of the rat","volume":"328","author":"Riediger","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110587_bib178","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(99)01697-2","article-title":"Pharmacological characterisation of amylin-related peptides activating subfornical organ neurones","volume":"837","author":"Riediger","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110587_bib179","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1152\/ajpregu.00333.2003","article-title":"The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis","volume":"286","author":"Riediger","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0031-9384(95)00108-U","article-title":"Central insulin enhances sensitivity to cholecystokinin","volume":"58","author":"Riedy","year":"1995","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib181","doi-asserted-by":"crossref","first-page":"E1112","DOI":"10.1152\/ajpendo.00395.2007","article-title":"Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats","volume":"293","author":"Roth","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib182","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1210\/en.2006-0393","article-title":"Antiobesity effects of the beta-cell hormone amylin in diet-induced Obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression","volume":"147","author":"Roth","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2025.110587_bib183","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.0706473105","article-title":"Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies","volume":"105","author":"Roth","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110587_bib184","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/ijo.2008.91","article-title":"Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced Obese rats","volume":"32","author":"Roth","year":"2008","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.neuropharm.2025.110587_bib185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0167-0115(97)01034-3","article-title":"Comparison of fos induced in rat brain by GLP-1 and amylin","volume":"71","author":"Rowland","year":"1997","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2025.110587_bib186","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1210\/endo.142.11.8593","article-title":"Inhibition of central amylin signaling increases food intake and body adiposity in rats","volume":"142","author":"Rushing","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2025.110587_bib187","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1210\/endo.141.2.7378","article-title":"Amylin: a novel action in the brain to reduce body weight","volume":"141","author":"Rushing","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2025.110587_bib188","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2007-978590","article-title":"Amylin and insulin interact to reduce food intake in rats","volume":"32","author":"Rushing","year":"2000","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.neuropharm.2025.110587_bib189","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0196-9781(02)00022-0","article-title":"Acute 3rd-ventricular amylin infusion potently reduces food intake but does not produce aversive consequences","volume":"23","author":"Rushing","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2025.110587_bib190","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(94)90388-3","article-title":"In vitro autoradiographic localization of amylin binding sites in rat brain","volume":"62","author":"Sexton","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110587_bib191","doi-asserted-by":"crossref","first-page":"E443","DOI":"10.1152\/ajpendo.2001.280.3.E443","article-title":"Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas","volume":"280","author":"Silvestre","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib192","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fnins.2013.00181","article-title":"The central GLP-1: implications for food and drug reward","volume":"7","author":"Skibicka","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110587_bib193","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1139\/y95-131","article-title":"Comparative immunohistochemical distribution of amylin-like and calcitonin gene related peptide like immunoreactivity in the rat central nervous system","volume":"73","author":"Skofitsch","year":"1995","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib69","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.15254","article-title":"Whole-brain mapping of amylin-induced neuronal activity in receptor activity\u2013modifying protein (RAMP) 1\/3 knockout mice","author":"Skovbjerg","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110587_bib194","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/dc08-0029","article-title":"Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity","volume":"31","author":"Smith","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neuropharm.2025.110587_bib195","doi-asserted-by":"crossref","first-page":"E620","DOI":"10.1152\/ajpendo.00217.2007","article-title":"Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study","volume":"293","author":"Smith","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2025.110587_bib196","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1016\/j.celrep.2017.11.036","article-title":"Nutritive, post-ingestive signals are the primary regulators of AgRP neuron activity","volume":"21","author":"Su","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2025.110587_bib197","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1096\/fj.11-191841","article-title":"Amylin is a novel neuropeptide with potential maternal functions in the rat","volume":"26","author":"Szabo","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2025.110587_bib198","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1163\/1568539X-00003305","article-title":"Behavioral changes in mothers and maternally sensitized female mice","volume":"152","author":"Szab\u00f3","year":"2015","journal-title":"Behaviour"},{"key":"10.1016\/j.neuropharm.2025.110587_bib199","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-3565(24)39040-8","article-title":"Amylin receptor phenotypes derived from human calcitonin receptor\/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment","volume":"294","author":"Tilakaratne","year":"2000","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110587_bib200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/oby.2009.187","article-title":"Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced Obese rats","volume":"18","author":"Trevaskis","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.neuropharm.2025.110587_bib201","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1210\/en.2010-0590","article-title":"Enhanced amylin-mediated body weight loss in estradiol-deficient diet-induced Obese rats","volume":"151","author":"Trevaskis","year":"2010","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110587_bib202","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/osp4.62","article-title":"Amylin\/Leptin synergy is absent in extreme obesity and not restored by calorie restriction-induced weight loss in rats","volume":"2","author":"Trevaskis","year":"2016","journal-title":"Obes. Sci. Pract."},{"key":"10.1016\/j.neuropharm.2025.110587_bib203","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/en.2009-0546","article-title":"Mechanisms of amylin\/leptin synergy in rodent models","volume":"151","author":"Turek","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2025.110587_bib204","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0169-328X(01)00179-6","article-title":"Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain","volume":"93","author":"Ueda","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuropharm.2025.110587_bib205","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/cne.902190307","article-title":"Organization of the projections of a circumventricular organ: the area postrema in the rat","volume":"219","author":"van der Kooy","year":"1983","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib206","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1055\/s-2007-978937","article-title":"Plasma amylin concentrations in fasted and fed rats quantified by a monoclonal immunoenzymometric assay","volume":"30","author":"Vine","year":"1998","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.neuropharm.2025.110587_bib207","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/acn3.197","article-title":"A second trigeminal CGRP receptor: function and expression of the AMY1 receptor","volume":"2","author":"Walker","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neuropharm.2025.110587_bib208","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.50.3.534","article-title":"The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site","volume":"50","author":"Wang","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2025.110587_bib209","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1677\/jme.1.01825","article-title":"The estrogen-responsive Adrenomedullin and receptor-modifying protein 3 gene identified by DNA microarray analysis are directly regulated by estrogen receptor","volume":"36","author":"Watanabe","year":"2006","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib210","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","article-title":"A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas","volume":"140","author":"Westermark","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2025.110587_bib211","doi-asserted-by":"crossref","first-page":"23009","DOI":"10.1074\/jbc.M114.624601","article-title":"Modulation of glucagon receptor pharmacology by receptor activity-modifying Protein-2 (RAMP2)","volume":"290","author":"Weston","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110587_bib212","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2174\/1381612013397357","article-title":"Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control","volume":"7","author":"Weyer","year":"2001","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2025.110587_bib213","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.physbeh.2017.03.023","article-title":"The area postrema (AP) and the parabrachial nucleus (PBN) are important sites for salmon calcitonin (sCT) to decrease evoked phasic dopamine release in the nucleus accumbens (NAc)","volume":"176","author":"Whiting","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib214","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.regpep.2008.03.010","article-title":"Gastric emptying in response to IAPP and CCK in rats with subdiaphragmatic afferent vagotomy","volume":"148","author":"Wickbom","year":"2008","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2025.110587_bib215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.physbeh.2010.04.012","article-title":"Central amylin acts as an adiposity signal to control body weight and energy expenditure","volume":"101","author":"Wielinga","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib216","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.physbeh.2004.04.050","article-title":"Lessons in the interactions of hormones and ingestive behavior","volume":"82","author":"Woods","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2025.110587_bib217","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1098\/rstb.2006.1858","article-title":"Pancreatic signals controlling food intake; insulin, glucagon and amylin","volume":"361","author":"Woods","year":"2006","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110587_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109204","article-title":"Calcitonin receptor signaling in the medial preoptic area enables risk-taking maternal care","volume":"35","author":"Yoshihara","year":"2021","journal-title":"Cell Rep."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2025.110587_bib219","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1002\/(SICI)1096-9136(199706)14:2+<S14::AID-DIA398>3.0.CO;2-Q","article-title":"Role of amylin in nutrient intake - animal studies","volume":"14","author":"Young","year":"1997","journal-title":"Diabet. Med."},{"key":"10.1016\/j.neuropharm.2025.110587_bib220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1054-3589(05)52006-4","article-title":"Inhibition of gastric emptying","volume":"52","author":"Young","year":"2005","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib221","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1054-3589(05)52008-8","article-title":"Inhibition of glucagon secretion","volume":"52","author":"Young","year":"2005","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib222","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1054-3589(05)52002-7","article-title":"Tissue expression and secretion of amylin","volume":"52","author":"Young","year":"2005","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib223","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/bcpt.13427","article-title":"Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases","volume":"127","author":"Zakariassen","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110587_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107987","article-title":"Salmon calcitonin distributes into the arcuate nucleus to a subset of NPY neurons in mice","volume":"167","author":"Zakariassen","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110587_bib225","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuron.2020.11.010","article-title":"Area postrema cell types that mediate nausea-associated behaviors","volume":"109","author":"Zhang","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110587_bib226","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.physbeh.2013.02.006","article-title":"Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli","volume":"112\u2013113","author":"Zuger","year":"2013","journal-title":"Physiol. Behav."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082500293X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082500293X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T09:20:18Z","timestamp":1779614418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082500293X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":225,"alternative-id":["S002839082500293X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110587","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of amylin in feeding and satiation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110587"}}